PMID- 30560269
OWN - NLM
STAT- MEDLINE
DCOM- 20190522
LR  - 20190522
IS  - 0371-0874 (Print)
IS  - 0371-0874 (Linking)
VI  - 70
IP  - 6
DP  - 2018 Dec 25
TI  - [Hyperhomocysteinemia and kidney diseases].
PG  - 607-611
AB  - Homocysteine (Hcy) is an intermediate metabolite of methionine metabolism. 
      Hyperhomocysteinemia (HHcy) is defined as a condition characterized by plasma Hcy 
      level above 16 mumol/L which can result from abnormal Hcy metabolism. HHcy has 
      been confirmed to be related to cardio-cerebrovascular disease, peripheral 
      vascular disorders, neurodegenerative diseases, diabetes, pregnancy-induced 
      hypertension syndrome, liver cirrhosis and kidney diseases. In this review, we 
      summarize the correlation between HHcy and kidney diseases. Elucidating the role 
      of HHcy in kidney diseases may provide a new strategy to prevent and treat kidney 
      diseases.
FAU - Zhou, Yun-Feng
AU  - Zhou YF
AD  - Medical Research Center, Physiology Department of Basic Medical College, Shenzhen 
      University Health Science Center, Shenzhen 518060, China.
FAU - Guan, You-Fei
AU  - Guan YF
AD  - Advanced Institute of Medical Sciences, Dalian Medical University, Dalian 116044, 
      China. guanyf@dmu.edu.cn.
LA  - chi
PT  - Journal Article
PT  - Review
PL  - China
TA  - Sheng Li Xue Bao
JT  - Sheng li xue bao : [Acta physiologica Sinica]
JID - 20730130R
RN  - 0LVT1QZ0BA (Homocysteine)
SB  - IM
MH  - Homocysteine
MH  - Humans
MH  - Hyperhomocysteinemia/*complications
MH  - Kidney Diseases/*complications
EDAT- 2018/12/19 06:00
MHDA- 2019/05/23 06:00
CRDT- 2018/12/19 06:00
PHST- 2018/12/19 06:00 [entrez]
PHST- 2018/12/19 06:00 [pubmed]
PHST- 2019/05/23 06:00 [medline]
PST - ppublish
SO  - Sheng Li Xue Bao. 2018 Dec 25;70(6):607-611.